Selected research
Industry Research
Crizotinib Capsules Industry Research Report 2026
Market perspective
The global Crizotinib Capsules market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Crizotinib Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Crizotinib Capsules is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Crizotinib Capsules is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Crizotinib Capsules include Chia Tai Tianqing Pharmaceutical Group, Cipla Limited, Glenmark Pharmaceuticals, Natco Pharma, Pfizer, Jiangsu Hengrui Medicine and Qilu Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Crizotinib Capsules market in terms of revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Crizotinib Capsules Market by Company
Chia Tai Tianqing Pharmaceutical Group
Cipla Limited
Glenmark Pharmaceuticals
Natco Pharma
Pfizer
Jiangsu Hengrui Medicine
Qilu Pharmaceutical
Crizotinib Capsules Segment by Type
200mg
250mg
Crizotinib Capsules Segment by Application
Hospital
Clinic
Others
Crizotinib Capsules Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crizotinib Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Crizotinib Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crizotinib Capsules.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Crizotinib Capsules manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Crizotinib Capsules by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Crizotinib Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 200mg
- 250mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- Chia Tai Tianqing Pharmaceutical Group
- Cipla Limited
- Glenmark Pharmaceuticals
- Natco Pharma
- Pfizer
- Jiangsu Hengrui Medicine
- Qilu Pharmaceutical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Crizotinib Capsules Market Size (2021-2032)
- 2.2.2 Global Crizotinib Capsules Sales (2021-2032)
- 2.2.3 Global Crizotinib Capsules Market Average Price (2021-2032)
- 2.3 Crizotinib Capsules by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 200mg
- 2.3.3 250mg
- 2.4 Crizotinib Capsules by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Crizotinib Capsules Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Crizotinib Capsules Sales (Tons) of Manufacturers (2021-2026)
- 3.3 Global Crizotinib Capsules Revenue of Manufacturers (2021-2026)
- 3.4 Global Crizotinib Capsules Average Price by Manufacturers (2021-2026)
- 3.5 Global Crizotinib Capsules Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Crizotinib Capsules, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Crizotinib Capsules, Product Type & Application
- 3.8 Global Manufacturers of Crizotinib Capsules, Established Date
- 3.9 Global Crizotinib Capsules Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chia Tai Tianqing Pharmaceutical Group
- 4.1.1 Chia Tai Tianqing Pharmaceutical Group Company Information
- 4.1.2 Chia Tai Tianqing Pharmaceutical Group Business Overview
- 4.1.3 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chia Tai Tianqing Pharmaceutical Group Crizotinib Capsules Product Portfolio
- 4.1.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments
- 4.2 Cipla Limited
- 4.2.1 Cipla Limited Company Information
- 4.2.2 Cipla Limited Business Overview
- 4.2.3 Cipla Limited Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Cipla Limited Crizotinib Capsules Product Portfolio
- 4.2.5 Cipla Limited Recent Developments
- 4.3 Glenmark Pharmaceuticals
- 4.3.1 Glenmark Pharmaceuticals Company Information
- 4.3.2 Glenmark Pharmaceuticals Business Overview
- 4.3.3 Glenmark Pharmaceuticals Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Glenmark Pharmaceuticals Crizotinib Capsules Product Portfolio
- 4.3.5 Glenmark Pharmaceuticals Recent Developments
- 4.4 Natco Pharma
- 4.4.1 Natco Pharma Company Information
- 4.4.2 Natco Pharma Business Overview
- 4.4.3 Natco Pharma Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Natco Pharma Crizotinib Capsules Product Portfolio
- 4.4.5 Natco Pharma Recent Developments
- 4.5 Pfizer
- 4.5.1 Pfizer Company Information
- 4.5.2 Pfizer Business Overview
- 4.5.3 Pfizer Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Pfizer Crizotinib Capsules Product Portfolio
- 4.5.5 Pfizer Recent Developments
- 4.6 Jiangsu Hengrui Medicine
- 4.6.1 Jiangsu Hengrui Medicine Company Information
- 4.6.2 Jiangsu Hengrui Medicine Business Overview
- 4.6.3 Jiangsu Hengrui Medicine Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Jiangsu Hengrui Medicine Crizotinib Capsules Product Portfolio
- 4.6.5 Jiangsu Hengrui Medicine Recent Developments
- 4.7 Qilu Pharmaceutical
- 4.7.1 Qilu Pharmaceutical Company Information
- 4.7.2 Qilu Pharmaceutical Business Overview
- 4.7.3 Qilu Pharmaceutical Crizotinib Capsules Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Qilu Pharmaceutical Crizotinib Capsules Product Portfolio
- 4.7.5 Qilu Pharmaceutical Recent Developments
5 Global Crizotinib Capsules Market Scenario by Region
- 5.1 Global Crizotinib Capsules Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Crizotinib Capsules Sales by Region: 2021-2032
- 5.2.1 Global Crizotinib Capsules Sales by Region: 2021-2026
- 5.2.2 Global Crizotinib Capsules Sales by Region: 2027-2032
- 5.3 Global Crizotinib Capsules Revenue by Region: 2021-2032
- 5.3.1 Global Crizotinib Capsules Revenue by Region: 2021-2026
- 5.3.2 Global Crizotinib Capsules Revenue by Region: 2027-2032
- 5.4 North America Crizotinib Capsules Market Facts & Figures by Country
- 5.4.1 North America Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Crizotinib Capsules Sales by Country (2021-2032)
- 5.4.3 North America Crizotinib Capsules Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Crizotinib Capsules Market Facts & Figures by Country
- 5.5.1 Europe Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Crizotinib Capsules Sales by Country (2021-2032)
- 5.5.3 Europe Crizotinib Capsules Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Crizotinib Capsules Market Facts & Figures by Country
- 5.6.1 Asia Pacific Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Crizotinib Capsules Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Crizotinib Capsules Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Crizotinib Capsules Market Facts & Figures by Country
- 5.7.1 South America Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Crizotinib Capsules Sales by Country (2021-2032)
- 5.7.3 South America Crizotinib Capsules Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Crizotinib Capsules Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Crizotinib Capsules Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Crizotinib Capsules Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Crizotinib Capsules Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Crizotinib Capsules Sales by Type (2021-2032)
- 6.1.1 Global Crizotinib Capsules Sales by Type (2021-2032) & (Tons)
- 6.1.2 Global Crizotinib Capsules Sales Market Share by Type (2021-2032)
- 6.2 Global Crizotinib Capsules Revenue by Type (2021-2032)
- 6.2.1 Global Crizotinib Capsules Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Crizotinib Capsules Revenue Market Share by Type (2021-2032)
- 6.3 Global Crizotinib Capsules Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Crizotinib Capsules Sales by Application (2021-2032)
- 7.1.1 Global Crizotinib Capsules Sales by Application (2021-2032) & (Tons)
- 7.1.2 Global Crizotinib Capsules Sales Market Share by Application (2021-2032)
- 7.2 Global Crizotinib Capsules Revenue by Application (2021-2032)
- 7.2.1 Global Crizotinib Capsules Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Crizotinib Capsules Revenue Market Share by Application (2021-2032)
- 7.3 Global Crizotinib Capsules Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Crizotinib Capsules Value Chain Analysis
- 8.1.1 Crizotinib Capsules Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Crizotinib Capsules Production Mode & Process
- 8.2 Crizotinib Capsules Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Crizotinib Capsules Distributors
- 8.2.3 Crizotinib Capsules Customers
9 Global Crizotinib Capsules Analyzing Market Dynamics
- 9.1 Crizotinib Capsules Industry Trends
- 9.2 Crizotinib Capsules Industry Drivers
- 9.3 Crizotinib Capsules Industry Opportunities and Challenges
- 9.4 Crizotinib Capsules Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst